An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these accounts directly for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where groups with thousands of members share comparison images, injection guides and assertions of next-day British shipping. Sellers market the drug there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Concerns
However, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in individuals administering products of uncertain source.
Some experts stated the demand for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate medicines, advertising, and consumer laws, risking penalties, prosecution or prison.
Platform Response and Content Removal
Based on the social media company, the platform has taken down problematic material and prohibited related keywords and search suggestions. The organization said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.
Digital Trading Activities
Research also discovered groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of slimming results, positive testimonials and step-by-step instructions for preparing or administering at residence.
After moments of entering one community, a seller shared contact information, where the majority of transactions occur. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, medical conditions or past usage.
Item Information and Pricing
Inside these groups, posts display dark colored packages with postal service stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how long a pen should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram said it actively moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they cannot confirm. Although the science behind this drug is sound, these online products may not include what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service linked the surge in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has already seen patients injured by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to potentially significant medical dangers”.
